摘要:
A lighting apparatus is disclosed. The lighting apparatus according to one embodiment of the present disclosure includes: a white light emitting device including at least one first light emitting diode and a wavelength converter to implement white light; and at least one second light emitting diode emitting light suitable for producing a cell activating substance, wherein the first light emitting diode emits light having a central wavelength in a range of about 300 nm to about 420 nm, the second light emitting diode emits light having a central wavelength in a range of about 605 nm to about 935 nm, the wavelength converter includes a plurality of wavelength conversion substances to convert light of the first light emitting diode into white light, the lighting apparatus emits the white light implemented in the white light emitting device and light generated by the second light emitting diode to the outside, and, in irradiance spectrum of the white light implemented in the white light emitting device, irradiance of the central wavelength of light emitted from the first light emitting diode is smaller than that of a peak wavelength of blue light emitted from the wavelength conversion substance.
摘要:
A portable, personal therapy chamber for provision of radiation therapy. The therapy chamber includes a pair of telescopically positionable units that are lightweight and easily portable by a single user. The therapy chamber is configured for use by a single person lying generally prone on a surface. The units are formed from a plurality of pivotably coupled panels that are foldable in a first direction to a rolled up, tube-like storage configuration and unfoldable in a second direction to an arched formation or use configuration. The units, in the use configuration, are disposed to overlie the user and include a plurality of emitters that direct infrared energy toward the user's body.
摘要:
The subject matter described herein is directed to articles, compositions, systems, and methods of using and preparing bioceramic compositions and to the bioceramic compositions. A bioceramic composition of the disclosure radiates infrared energy or rays and can be used in the treatment of various conditions.
摘要:
A spiky metal organic framework is provided in the present disclosure. The spiky metal organic framework is formed by a coordination reaction between at least one metal ion and an organic ligand, and includes a body and a plurality of spike-like structures. The body is a spherical shape, and a particle size of the body is 1 μm to 3 μm. The spike-like structures are distributed on a surface of the body, a diameter of each spike-like structure is 15 nm to 35 nm, and a length of each spike-like structure is 250 nm to 400 nm.
摘要:
This invention relates to a therapeutic device for treating a human or animal body, comprising an array of infrared-emitting elements disposed on or within a flexible substrate and attached to the body part to be treated using an attachment means, said array comprising a first plurality of infrared-emitting ceramic elements having a specific spectral luminance covering at least a part of the 3-7 micrometer wavelength spectrum and having a peak wavelength between 3 and 7 micrometers, and a second plurality of infrared-emitting ceramic elements having a specific spectral luminance covering at least a part of the 7-14 micrometer wavelength spectrum and having a peak wavelength between 7 and 14, that provides an effective means to healing the body.
摘要:
Optical energy delivery apparatus for ablation or embolization includes an optical fibre having a distal end which is provided a light directing element, such as a lens. The light directing element is configured to direct optical energy beyond the distal end of the optical fibre. The optical fibre includes at least one Bragg grating proximate the distal end for sensing a change in the optical fibre during its operation. The apparatus includes a control unit configured to drive an optical source and to obtain signals from a sensor unit. The controller may also drive the energy source at a sensing wavelength. The structure provides a single optical fibre supply optical energy and sense changes in optical fibre. The optical fibre may have a tapering diameter towards its distal tip for increased flexibility at its distal end.
摘要:
An infrared sudation device includes a support element (1) extending along a longitudinal axis (X) and a cover element (2a, 2b) of semicylindrical shape mounted on the support element (1) so as to delimit an internal volume extending in the longitudinal direction between the support element and the internal surface of the cover element. The internal surface of the cover element is covered at least in part with a heating layer (3a, 3b) able to emit far-infrared radiation in at least part of the internal volume. The infrared sudation device includes a housing of photocatalyst (4), permeable to the infrared radiation emitted, supporting a photocatalyst (5) and arranged in proximity to the internal face of the heating layer (3a, 3b) so as to allow the photocatalyst to be activated using the energy supplied by the infrared radiation emitted.
摘要:
The subject matter described herein is directed to articles, compositions, systems, and methods of using and preparing bioceramic compositions and to the bioceramic compositions. A bioceramic composition of the disclosure radiates infrared energy or rays and can be used in the treatment of various conditions.
摘要:
The subject matter described herein is directed to articles, compositions, systems, and methods of using and preparing bioceramic compositions and to the bioceramic compositions. A bioceramic composition of the disclosure radiates infrared energy or rays and can be used in the treatment of various conditions.
摘要:
Provided herein are photochromic organic compounds of Formula I or Formula II, which are useful as molecular switches capable of being triggered via a cis/trans isomerization process. Methods of using the molecular switch compounds to form photopharmaceutical compounds that may be used to provide selective spatiotemporal activation of pharmaceutical agents are also disclosed.